Lionheart Acquisition Corp. II (NASDAQ:LCAP) announced that its shareholders have voted to approve its combination with Medicare billing firm MSP Recovery in a special meeting held earlier today.
Although today’s press release did not disclose redemption numbers, Lionheart II traded above its trust value of $10 throughout its redemption deadline Monday, May 16, and opened today at $10.49.
The SPAC announced last week that it had secured a funded and committed equity facility with an affiliate of Cantor, which allowed Cantor to purchase up to 3.5 million shares from LCAP stockholders who have elected to redeem their shares at or below the redemption price. This provides some security to Lionheart II in its redemptions situation and covers the deal’s $30 million minimum cash condition.
Lionheart II also announced last week that its previously disclosed pool of 1,029,000,000 warrants will be distributed to non-redeeming shareholders. Non-redeeming shareholders will receive these as a dividend on the 10th day following closing of the combination.
The parties expect to close the business combination on Friday, May 20, 2022. Following the closing, the shares of Class A Common Stock of the combined company are anticipated to continue to be traded on Nasdaq under the symbol “MSPR”. The combined company’s public warrants are anticipated to continue to be traded on Nasdaq under the symbol “LCAPW”, and the new warrants issued in connection with the previously announced and declared LCAP dividend are anticipated to commence trading on Nasdaq under the symbol “MSPRW” when issued.
LCAP initially announced its $32.6 billion combination with MSP Recovery on July 12, 2021. Coral Gables, Florida-based MSP has built a proprietary model for identifying and acquiring claims against primary care payers in the healthcare industry that unduly passed costs onto Medicare, Medicaid and other payors.
Five other proposals were also considered and voted upon by LCAP’s stockholders at today’s special meeting, all of which were approved.
ADVISORS
- Keefe, Bruyette & Woods, a Stifel Company, is serving as financial advisor to MSP Recovery.
- Nomura Securities International, Inc. is serving as financial and capital markets advisor to Lionheart Acquisition Corp II.
- Weil, Gotshal & Manges LLP is serving as legal counsel to MSP Recovery.
- DLA Piper LLP is serving as legal counsel to Lionheart Acquisition Corp II.
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...
Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...